Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Prostate Specific Antigen Kit ELISA

Ce kit ELISA Colorimetric est destiné à la mesure quantitative de Humain Prostate Specific Antigen.
N° du produit ABIN5526768
586,60 €
Plus frais de livraison 40,00 € et TVA
96 tests
Destination: France
Envoi sous 7 à 10 jours ouvrables

Aperçu rapide pour Prostate Specific Antigen Kit ELISA (ABIN5526768)

Antigène

Voir toutes Prostate Specific Antigen (PSA) Kits ELISA
Prostate Specific Antigen (PSA)

Reactivité

  • 28
  • 12
  • 10
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Méthode de détection

Colorimetric

Type de méthode

Sandwich ELISA

Gamme de detection

0.04 ng/mL - 40 ng/mL

Application

ELISA

Type d'échantillon

Plasma, Cell Culture Supernatant, Serum
  • Seuil minimal de détection

    0.04 ng/mL

    Fonction

    This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human PSA.

    Analytical Method

    Quantitative

    Specificité

    PSA

    Ingrédients

    • Plate
    • Standard
    • Diluent

    Matériel non inclus

    Microplate reader capable of measuring absorbance at 450 nm, with correction wavelength set at 570 nm or 630 nm.
    Pipettes and pipette tips.
    50 μL to 300 μL adjustable multichannel micropipette with disposable tips.
    Multichannel micropipette reservoir.
    Beakers, flasks, cylinders necessary for preparation of reagents.
    Deionized or distilled water.
    Polypropylene test tubes for dilution.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Volume d'échantillon

    100 μL

    Durée du test

    3 - 4 h

    Plaque

    Pre-coated

    Restrictions

    For Research Use only
  • Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    protect your eyes

    Stock

    4 °C

    Stockage commentaire

    Store kit reagents between 2 and 8 °C. Immediately after use remaining reagents should be returned to cold storage (2 to 8 °C).
    Expiry of the kit and reagents is stated on labels. Expiration date of the kit components can only be guaranteed if the components are stored properly, and if, in case of repeated use of one component, this reagent is not contaminated by the first handling.
    Unopened Kit: Store at 2 - 8 °C (See expiration date on the label).
    Opened/Reconstituted Reagents: Up to 1 month at 2 - 8 °C.
    Reconstituted Standard: Up to 1 month at ≤ -20 °C in a manual defrost freezer. Avoid repeated freeze-thaw cycles.
    Microplate Wells: Up to 1 month at 2 - 8 °C. Return unused strips to the foil pouch containing the desiccant pack, reseal along entire edge to maintain plate integrity. Provided this is within the expiration date of the kit
  • Antigène Voir toutes Prostate Specific Antigen (PSA) Kits ELISA

    Prostate Specific Antigen (PSA)

    Autre désignation

    KLK3

    Sujet

    Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland. PSA is produced for the ejaculate, where it liquefies semen in the seminal coagulum and allows sperm to swim freely. It is also believed to be instrumental in dissolving cervical mucus, allowing the entry of sperm into the uterus. PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer or other prostate disorders. Obesity has been reported to reduce serum PSA levels. PSA levels can be also increased by prostatitis, irritation and benign prostatic hyperplasia producing a false positive result. PSA is not a unique indicator of prostate cancer, but may also detect prostatitis or benign prostatic hyperplasia. 30 percent of patients with high PSA have prostate cancer diagnosed after biopsy. Clinical practice guidelines for prostate cancer screening vary and are controversial due to uncertainty as to whether the benefits of screening ultimately outweigh the risks of overdiagnosis and over treatment.

    ID gène

    354

    NCBI Accession

    NM_001030047

    UniProt

    P07288

    Pathways

    Système du Complément
Vous êtes ici:
Chat with us!